Premium
Mild behavioral impairment as a potential marker of predementia risk states in motor neuron diseases
Author(s) -
Ferraro Pilar M.,
Gervino Ester,
De Maria Emiliano,
Meo Giuseppe,
Ponzano Marta,
Pardini Matteo,
Signori Alessio,
Sche Angelo,
Roccatagliata Luca,
Caponnetto Claudia
Publication year - 2023
Publication title -
european journal of neurology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.881
H-Index - 124
eISSN - 1468-1331
pISSN - 1351-5101
DOI - 10.1111/ene.15570
Subject(s) - apathy , dementia , amyotrophic lateral sclerosis , cognitive decline , mood , medicine , cognition , longitudinal study , disease , psychiatry , clinical psychology , psychology , physical medicine and rehabilitation , audiology , pathology
Abstract Background and purpose Mild behavioral impairment (MBI) has been increasingly regarded as the neurobehavioral axis of predementia risk states, but a specific investigation of its detection as a potential marker of prodromal dementia in motor neuron diseases (MNDs) is still lacking. The aims of our study were therefore to explore MBI in MNDs both at onset and over the disease course, and to evaluate its relationship with baseline and longitudinal cognitive features. Methods Sixty MND patients with cognitive/behavioral, mood, and motor examinations were recruited and followed longitudinally for up to 15 months. Associations between baseline MBI symptoms and clinical features were tested using the Spearman correlation coefficient. Based on longitudinal data, relative deltas of variation for each cognitive measure were generated, and linear regression models were then used to evaluate the role of baseline MBI symptoms in predicting longitudinal rates of cognitive decline. Results At disease onset, the most impaired MBI domain was affective/emotional dysregulation, followed by impulse dyscontrol, apathy, and social inappropriateness. Greater MBI symptoms correlated with more severe baseline motor, cognitive/behavioral, and mood disturbances ( p values from <0.001 to 0.05). Longitudinally, the greatest decline was observed in the affective/emotional dysregulation domain, followed by impulse dyscontrol, apathy, and social inappropriateness. Greater MBI symptoms at onset were significant predictors of more severe longitudinal cognitive decline in both amyotrophic lateral sclerosis (ALS)‐specific and ALS‐nonspecific functions ( p values from <0.001 to 0.03). Conclusions MBI represents a valuable clinical marker of incident cognitive decline in MNDs, and its evaluation has good potential for detecting dementia in its preclinical/prodromal phase.